• Menke A, Casagrande S, Geiss L, Cowie CC. Prevalence of and trends in diabetes among adults in the United States, 1988-2012. JAMA. 2015;314(10):1021–9. This article contains the most up-to-date diabetes prevalence estimates for the United States.
Courtney-Long EA, Carroll DD, Zhang QC, Stevens AC, Griffin-Blake S, Armour BS, et al. Prevalence of disability and disability type among adults—United States, 2013. Mmwr-Morbid Mortal W. 2015;64(29):777–83.
Kochanek KD, Murphy SL, Xu J, Tejada-Vera B. Deaths: final data for 2014. National Center for Health Statistics, Division of Vital Statistics. 2016;65(4):1–122.
Dieleman JL, Baral R, Birger M, Bui AL, Bulchis A, Chapin A, et al. US spending on personal health care and public health, 1996-2013. JAMA. 2016;316(24):2627–46.
Golden SH, Brown A, Cauley JA, Chin MH, Gary-Webb TL, Kim C, et al. Health disparities in endocrine disorders: biological, clinical, and nonclinical factors—an Endocrine Society scientific statement. J Clin Endocrinol Metab. 2012;97(9):E1579–639.
National Center for Health Statistics. Health, United States, 2015: with special feature on racial and ethnic health disparities, Hyattsville, MD, 2016.
Kindig DA. Understanding population health terminology. Milbank Q. 2007;85(1):139–61.
Stiefel M, Nolan K. A guide to measuring the triple aim: population health, experience of care, and per capital costs. Cambridge: Institute for Healthcare Improvement; 2012.
Dunn JR, Hayes MV. Toward a lexicon of population health. Canadian Journal of Public Health-Revue Canadienne De Sante Publique. 1999;90:S7–S10.
Mathioudakis N, Golden SH. A comparison of inpatient glucose management guidelines: implications for patient safety and quality. Current Diabetes Reports. 2015;15(3):13.
Moghissi ES, Korytkowski MT, DiNardo M, Einhorn D, Hellman R, Hirsch IB, et al. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Endocr Pract. 2009;15(4):353–69.
American Diabetes Association. Standards of medical care in diabetes—2014. Diabetes Care. 2014;37(Suppl 1):S14–80.
Umpierrez GE, Hellman R, Korytkowski MT, Kosiborod M, Maynard GA, Montori VM, et al. Management of hyperglycemia in hospitalized patients in non-critical care setting: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2012;97(1):16–38.
Maynard G, Schnipper JL, Messler J, Ramos P, Kulasa K, Nolan A, et al. Design and implementation of a web-based reporting and benchmarking center for inpatient glucometrics. Journal of diabetes science and technology. 2014;8(4):630–40.
Thomas P, Inzucchi SE. An internet service supporting quality assessment of inpatient glycemic control. Journal of diabetes science and technology. 2008;2(3):402–8.
https://www.cms.gov/Medicare/Quality-Initiatives-Patient-Assessment-Instruments/QualityMeasures/index.html?redirect=/qualitymeasures/. Accessed 9 Mar 2017.
American Diabetes Association. Classification and diagnosis of diabetes. Diabetes Care. 2017;40:S11–24.
National Center for Chronic Disease Prevention and Health Promotion Division of Diabetes Translation: about prediabetes and type 2 diabetes. 2016. http://www.cdc.gov/diabetes/prevention/prediabetes-type2/index.html.
Centers for Disease Control and Prevention. Awareness of prediabetes—United States, 2005-2010. MMWR Morb Mortal Wkly Rep. 2013;62(11):209–12.
Kosaka K, Noda M, Kuzuya T. Prevention of type 2 diabetes by lifestyle intervention: a Japanese trial in IGT males. Diabetes Res Clin Pract. 2005;67(2):152–62.
Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. NEngl J Med. 2002;346(6):393–403.
Diabetes Prevention Program Research Group, Knowler WC, Fowler SE, Hamman RF, Christophi CA, Hoffman HJ, et al. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet. 2009;374(9702):1677–86. doi:10.1016/S0140-6736(09)61457-4.
•• Diabetes Prevention Program Research Group. Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the Diabetes Prevention Program Outcomes Study. The lancet Diabetes & endocrinology. 2015;3(11):866–75. This article summarizes the long-term effects of the Diabetes Prevention Program interventions on the risk of microvascular complications of diabetes.
Perreault L, Pan Q, Mather KJ, Watson KE, Hamman RF, Kahn SE, et al. Effect of regression from prediabetes to normal glucose regulation on long-term reduction in diabetes risk: results from the Diabetes Prevention Program Outcomes Study. Lancet. 2012;379(9833):2243–51.
Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344(18):1343–50.
Ramachandran A, Snehalatha C, Mary S, Mukesh B, Bhaskar AD, Vijay V, et al. The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia. 2006;49(2):289–97.
Pan XR, Li GW, Hu YH, Wang JX, Yang WY, An ZX, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care. 1997;20(4):537–44.
Li G, Zhang P, Wang J, Gregg EW, Yang W, Gong Q, et al. The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study. Lancet. 2008;371(9626):1783–9.
Li G, Zhang P, Wang J, An Y, Gong Q, Gregg EW, et al. Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing Diabetes Prevention Study: a 23-year follow-up study. The lancet Diabetes & endocrinology. 2014;2(6):474–80.
Ackermann RT, Finch EA, Caffrey HM, Lipscomb ER, Hays LM, Saha C. Long-term effects of a community-based lifestyle intervention to prevent type 2 diabetes: the DEPLOY extension pilot study. Chronic illness. 2011;7(4):279–90.
Balk EM, Earley A, Raman G, Avendano EA, Pittas AG, Remington PL. Combined diet and physical activity promotion programs to prevent type 2 diabetes among persons at increased risk: a systematic review for the Community Preventive Services Task Force. Ann Intern Med. 2015;163(6):437–51.
Diabetes Prevention Program Research G. The 10-year cost-effectiveness of lifestyle intervention or metformin for diabetes prevention: an intent-to-treat analysis of the DPP/DPPOS. Diabetes Care. 2012;35(4):723–30.
Li R, Qu S, Zhang P, Chattopadhyay S, Gregg EW, Albright A, et al. Economic evaluation of combined diet and physical activity promotion programs to prevent type 2 diabetes among persons at increased risk: a systematic review for the Community Preventive Services Task Force. Ann Intern Med. 2015;163(6):452–60.
Cefalu WT, Buse JB, Tuomilehto J, Fleming GA, Ferrannini E, Gerstein HC, et al. Update and next steps for real-world translation of interventions for type 2 diabetes prevention: reflections from a diabetes care editors’ expert forum. Diabetes Care. 2016;39(7):1186–201.
Saaristo T, Moilanen L, Korpi-Hyovalti E, Vanhala M, Saltevo J, Niskanen L, et al. Lifestyle intervention for prevention of type 2 diabetes in primary health care: one-year follow-up of the Finnish National Diabetes Prevention Program (FIN-D2D). Diabetes Care. 2010;33(10):2146–51.
Schwarz PE, Lindstrom J, Kissimova-Scarbeck K, Szybinski Z, Barengo NC, Peltonen M, et al. The European perspective of type 2 diabetes prevention: diabetes in Europe—prevention using lifestyle, physical activity and nutritional intervention (DE-PLAN) project. Experimental and clinical endocrinology & diabetes: official journal, German Society of Endocrinology [and] German Diabetes Association. 2008;116(3):167–72.
National Diabetes Prevention Program. https://www.congress.gov/bill/111th-congress/house-bill/4124. Accessed 8 Mar 2017.
Diabetes Prevention Recognition Program. https://nccd.cdc.gov/DDT_DPRP/Registry.aspx Accessed 8 Jan 2017.
Center for Disease Control and Prevention diabetes prevention recognition program: Standards and operating procedures. 2015. http://www.cdc.gov/diabetes/prevention/pdf/dprp-standards.pdf. Accessed 8 Mar 2017.
Office of the Actuary. Certification of Medicare diabetes prevention program. Baltimore: Centers for Medicare and Medicaid Services; 2016.
• Powers MA, Bardsley J, Cypress M, Duker P, Funnell MM, Hess Fischl A, et al. Diabetes self-management education and support in type 2 diabetes: a Joint position statement of the American Diabetes Association, the American Association of Diabetes Educators, and the Academy of Nutrition and Dietetics. Diabetes Care. 2015;38(7):1372–82. This article provides current state of the art recommendations for diabetes self-management education and support for patients with type 2 diabetes.
American Diabetes Association. Lifestyle management. Diabetes Care. 2017;40(Suppl. 1):S33–43.
Duke SA, Colagiuri S, Colagiuri R. Individual patient education for people with type 2 diabetes mellitus. The Cochrane database of systematic reviews. 2009;1:CD005268.
Steinsbekk A, Rygg LO, Lisulo M, Rise MB, Fretheim A. Group based diabetes self-management education compared to routine treatment for people with type 2 diabetes mellitus. A systematic review with meta-analysis. BMC Health Serv Res. 2012;12:213.
Sigurdardottir AK, Jonsdottir H, Benediktsson R. Outcomes of educational interventions in type 2 diabetes: WEKA data-mining analysis. Patient Educ Couns. 2007;67(1–2):21–31.
Attridge M, Creamer J, Ramsden M, Cannings-John R, Hawthorne K. Culturally appropriate health education for people in ethnic minority groups with type 2 diabetes mellitus. The Cochrane database of systematic reviews. 2014;9:CD006424.
Joseph JJ, Golden SH. Diabetes in native populations and underserved communities in the USA. In: Dagogo-Jack S, editor. Diabetes mellitus in developing and underserved communities. Switzerland: Springer International Publishing; 2017. p. 251–84.
Tricco AC, Ivers NM, Grimshaw JM, Moher D, Turner L, Galipeau J, et al. Effectiveness of quality improvement strategies on the management of diabetes: a systematic review and meta-analysis. Lancet. 2012;379(9833):2252–61.
Shojania KG, Ranji SR, McDonald KM, Grimshaw JM, Sundaram V, Rushakoff RJ, et al. Effects of quality improvement strategies for type 2 diabetes on glycemic control: a meta-regression analysis. JAMA. 2006;296(4):427–40.
Pimouguet C, Le Goff M, Thiebaut R, Dartigues JF, Helmer C. Effectiveness of disease-management programs for improving diabetes care: a meta-analysis. CMAJ: Canadian Medical Association journal = journal de l’Association medicale canadienne. 2011;183(2):E115–27.
Glazier RH, Bajcar J, Kennie NR, Willson K. A systematic review of interventions to improve diabetes care in socially disadvantaged populations. Diabetes Care. 2006;29(7):1675–88.
Peek ME, Cargill A, Huang ES. Diabetes health disparities: a systematic review of health care interventions. Med Care Res Rev. 2007;64(5):101S–56S.
Ricci-Cabello I, Ruiz-Perez I, Olry dL, Marquez-Calderon S. Do social inequalities exist in terms of the prevention, diagnosis, treatment, control and monitoring of diabetes? A systematic review. Health Soc Care Community. 2010;18(6):572–87.
Shah M, Kaselitz E, Heisler M. The role of community health workers in diabetes: update on current literature. Current diabetes reports. 2013;13(2):163–71.
Hunt CW, Grant JS, Appel SJ. An integrative review of community health advisors in type 2 diabetes. J Community Health. 2011;36(5):883–93.
Norris SL, Chowdhury FM, Van Le K, Horsley T, Brownstein JN, Zhang X, et al. Effectiveness of community health workers in the care of persons with diabetes. Diabetic medicine: a journal of the British Diabetic Association. 2006;23(5):544–56.
Gary TL, Batts-Turner M, Yeh HC, Hill-Briggs F, Bone LR, Wang NY, et al. The effects of a nurse case manager and a community health worker team on diabetic control, emergency department visits, and hospitalizations among urban African Americans with type 2 diabetes mellitus: a randomized controlled trial. Arch Intern Med. 2009;169(19):1788–94.
Kane EP, Collinsworth AW, Schmidt KL, Brown RM, Snead CA, Barnes SA, et al. Improving diabetes care and outcomes with community health workers. Fam Pract. 2016;33(5):523–8.
Fox CH, Mahoney MC. Improving diabetes preventive care in a family practice residency program: a case study in continuous quality improvement. Fam Med. 1998;30(6):441–5.
Phillips LS, Hertzberg VS, Cook CB, El-Kebbi IM, Gallina DL, Ziemer DC, et al. The Improving Primary Care of African Americans with Diabetes (IPCAAD) project: rationale and design. Control Clin Trials. 2002;23(5):554–69.
Phillips LS, Ziemer DC, Doyle JP, Barnes CS, Kolm P, Branch WT, et al. An endocrinologist-supported intervention aimed at providers improves diabetes management in a primary care site: improving primary care of African Americans with diabetes (IPCAAD) 7. Diabetes Care. 2005;28(10):2352–60.
Ziemer DC, Tsui C, Caudle J, Barnes CS, Dames F, Phillips LS. An informatics-supported intervention improves diabetes control in a primary care setting. AMIA annual symposium proceedings/amia symposium amia symposium. 2006:1160.
Ricci-Cabello I, Ruiz-Perez I, Nevot-Cordero A, Rodriguez-Barranco M, Sordo L, Goncalves DC. Health care interventions to improve the quality of diabetes care in African Americans: a systematic review and meta-analysis. Diabetes Care. 2013;36(3):760–8.
Thaler LM, Ziemer DC, Gallina DL, Cook CB, Dunbar VG, Phillips LS, et al. Diabetes in urban African-Americans. XVII. Availability of rapid HbA1c measurements enhances clinical decision-making. Diabetes Care. 1999;22(9):1415–21.
Cook CB, Penman A, Cobb AB, Miller D, Murphy T, Horn T. Outpatient diabetes management of Medicare beneficiaries in four Mississippi fee-for-service primary care clinics. J Miss State Med Assoc. 1999;40(1):8–13.
Bray P, Thompson D, Wynn JD, Cummings DM, Whetstone L. Confronting disparities in diabetes care: the clinical effectiveness of redesigning care management for minority patients in rural primary care practices. The Journal of rural health: official journal of the American Rural Health Association and the National Rural Health Care Association. 2005;21(4):317–21.
Anderson-Loftin W, Barnett S, Sullivan P, Bunn PS, Tavakoli A. Culturally competent dietary education for southern rural African Americans with diabetes. The Diabetes educator. 2002;28(2):245–57.
Mahotiere T, Ocepek-Welikson K, Daley MB, Byssainthe JP. A program to reduce the disparity in the rate of biennial lipid profiles between African-American and white Medicare beneficiaries with diabetes mellitus in New York City. J Community Health. 2006;31(4):263–88.
Rith-Najarian S, Branchaud C, Beaulieu O, Gohdes D, Simonson G, Mazze R. Reducing lower-extremity amputations due to diabetes—application of the staged diabetes management approach in a primary care setting. J Fam Pract. 1998;47(2):127–32.
Li R, Zhang P, Barker LE, Chowdhury FM, Zhang X. Cost-effectiveness of interventions to prevent and control diabetes mellitus: a systematic review. Diabetes Care. 2010;33(8):1872–94.
Richard P, Shin P, Beeson T, Burke LS, Wood SF, Rosenbaum S. Quality and cost of diabetes mellitus care in Community Health Centers in the United States. PLoS One. 2015;10(12):e0144075.
Huang ES, Brown SE, Zhang JX, Kirchhoff AC, Schaefer CT, Casalino LP, et al. The cost consequences of improving diabetes care: the community health center experience. Joint Commission journal on quality and patient safety/Joint Commission Resources. 2008;34(3):138–46.
Bodenheimer T, Wagner EH, Grumbach K. Improving primary care for patients with chronic illness. JAMA. 2002;288(14):1775–9.
Wagner EH, Sandhu N, Newton KM, McCulloch DK, Ramsey SD, Grothaus LC. Effect of improved glycemic control on health care costs and utilization. JAMA. 2001;285(2):182–9.
Ansell D, Schiff R, Goldberg D, Furumoto-Dawson A, Dick S, Peterson C. Primary care access decreases nonurgent hospital visits for indigent diabetics. J Health Care Poor Underserved. 2002;13(2):171–83.
Sadur CN, Moline N, Costa M, Michalik D, Mendlowitz D, Roller S, et al. Diabetes management in a health maintenance organization. Efficacy of care management using cluster visits. Diabetes Care. 1999;22(12):2011–7.
Nason GJ, Strapp H, Kiernan C, Moore K, Gibney J, Feeley TM, et al. The cost utility of a multi-disciplinary foot protection clinic (MDFPC) in an Irish hospital setting. Ir J Med Sci. 2013;182(1):41–5.
Schouten LM, Niessen LW, van de Pas JW, Grol RP, Hulscher ME. Cost-effectiveness of a quality improvement collaborative focusing on patients with diabetes. Med Care. 2010;48(10):884–91.
Wagner EH, Grothaus LC, Sandhu N, Galvin MS, McGregor M, Artz K, et al. Chronic care clinics for diabetes in primary care: a system-wide randomized trial. Diabetes Care. 2001;24(4):695–700.
de Weerdt I, Visser AP, Kok GJ, de Weerdt O, van der Veen EA. Randomized controlled multicentre evaluation of an education programme for insulin-treated diabetic patients: effects on metabolic control, quality of life, and costs of therapy. Diabet Med. 1991;8(4):338–45.
Dougherty G, Schiffrin A, White D, Soderstrom L, Sufrategui M. Home-based management can achieve intensification cost-effectively in type I diabetes. Pediatrics. 1999;103(1):122–8.
HCUP Nationwide Inpatient Sample (NIS). Agency for healthcare research and quality. 2010. http://hcupnet.ahrq.gov/HCUPnet.jsp. Accessed 5 June 2014:2014.
CDC. Number (in thousands) of hospital discharges with diabetes as any-listed diagnosis, United States, 1988–2009. Centers for Disease Control and Prevention (CDC), National Center for Health Statistics. http://www.cdc.gov/diabetes/statistics/dmany/fig1.htm. Accessed 11 June 2014:2014.
Centers for Disease C, Prevention. Increasing prevalence of diagnosed diabetes—United States and Puerto Rico, 1995-2010. MMWR Morb Mortal Wkly Rep. 2012;61(45):918–21.
Jones AP, Homer JB, Murphy DL, Essien JD, Milstein B, Seville DA. Understanding diabetes population dynamics through simulation modeling and experimentation. Am J Public Health. 2006;96(3):488–94.
Centers for Disease C, Prevention. National Diabetes Fact Sheet: national estimates and general information on diabetes and prediabetes in the United States, 2011.2012. http://www.cdc.gov/diabetes/pubs/pdf/ndfs_2011.pdf.
American Diabetes Association. Economic costs of diabetes in the U.S. Diabetes Care. 2008;31(3):1–20.
Kim S. Burden of hospitalizations primarily due to uncontrolled diabetes: implications of inadequate primary health care in the United States. Diabetes Care. 2007;30(5):1281–2.
Curkendall SM, Natoli JL, Alexander CM, Nathanson BH, Haidar T, Dubois RW. Economic and clinical impact of inpatient diabetic hypoglycemia. Endocr Pract. 2009;15(4):302–12.
ACE/ADA Task Force on Inpatient Diabetes. American College of Endocrinology and American Diabetes Association consensus statement on inpatient diabetes and glycemic control. Endocr Pract. 2006;12(Suppl 3):4–13.
Moghissi ES, Korytkowski MT, DiNardo M, Einhorn D, Hellman R, Hirsch IB, et al. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Diabetes Care. 2009;32(6):1119–31.
The Joint Commission. Advanced certification in inpatient diabetes. The Joint Commission. http://www.jointcommission.org/certification/inpatient_diabetes.aspx. Accessed 8 Mar 2017.
Munoz C, Lowry C, Smith C. Continuous quality improvement: hypoglycemia prevention in the postoperative surgical population. Medsurg Nurs. 2012;21(5):275–80.
Trujillo JM, Barsky EE, Greenwood BC, Wahlstrom SA, Shaykevich S, Pendergrass ML, et al. Improving glycemic control in medical inpatients: a pilot study. J Hosp Med. 2008;3(1):55–63.
Herring R, Pengilley C, Hopkins H, Tuthill B, Patel N, Nelson C, et al. Can an interprofessional education tool improve healthcare professional confidence, knowledge and quality of inpatient diabetes care: a pilot study? Diabet Med. 2013;30(7):864–70.
Donaldson S, Villanuueva G, Rondinelli L, Baldwin D. Rush University guidelines and protocols for the management of hyperglycemia in hospitalized patients: elimination of the sliding scale and improvement of glycemic control throughout the hospital. The Diabetes educator. 2006;32(6):954–62.
Lee J, Clay B, Zelazny Z, Maynard G. Indication-based ordering: a new paradigm for glycemic control in hospitalized inpatients. Journal of diabetes science and technology. 2008;2(3):349–56.
Schnipper JL, Ndumele CD, Liang CL, Pendergrass ML. Effects of a subcutaneous insulin protocol, clinical education, and computerized order set on the quality of inpatient management of hyperglycemia: results of a clinical trial. J Hosp Med. 2009;4(1):16–27.
Flanders SJ, Juneja R, Roudebush CP, Carroll J, Golas A, Elias BL. Glycemic control and insulin safety: the impact of computerized intravenous insulin dosing. American journal of medical quality: the official journal of the American College of Medical Quality. 2009;24(6):489–97.
Gilman JA. A quality improvement project for better glycemic control in hospitalized patients with diabetes. The Diabetes educator. 2001;27(4):541–6.
Pasala S, Dendy JA, Chockalingam V, Meadows RY. An inpatient hypoglycemia committee: development, successful implementation, and impact on patient safety. Ochsner J. 2013;13(3):407–12.
Korytkowski M, Dinardo M, Donihi AC, Bigi L, Devita M. Evolution of a diabetes inpatient safety committee. Endocr Pract. 2006;12(Suppl 3):91–9.
Draznin B, Gilden J, Golden SH, Inzucchi SE, PRIDE investigators, Baldwin D, et al. Pathways to quality inpatient management of hyperglycemia and diabetes: a call to action. Diabetes Care. 2013;36(7):1807–14.
Boffa DP, Pawola LM. Identification and conceptualization of nurse super users. J Healthc Inf Manag. 2006;20(4):60–8.
McIntire S, Clark T. Essential steps in super user education for ambulatory clinic nurses. Urol Nurs. 2009;29(5):337–42. quiz 43
Selig PM, Popek V, Peebles KM. Minimizing hypoglycemia in the wake of a tight glycemic control protocol in hospitalized patients. J Nurs Care Qual. 2010;25(3):255–60.
Murphy DM, Vercruysse RA, Bertucci TM, Wall MJ, Schriever AE, Nabhan FA, et al. Reducing hyperglycemia hospitalwide: the basal-bolus concept. Joint Commission journal on quality and patient safety/Joint Commission Resources. 2009;35(4):216–23.
Kemmerer T, Bashura H, Dintzis J, Mathioudakis N, Golden SH. The impact of nursing and advanced practice clinician on the implementation and outcomes of an inpatient glucose management program. AADE In Practice. 2015:17–25.
Golden SH, Hager D, Gould LJ, Mathioudakis N, Pronovost P. A gap analysis needs assessment tool to drive a care delivery and research agenda for integration of care and sharing of best practices across a health system. The Joint Commission Journal on Quality and Patient Safety. 2017;43:18–28.
Ena J, Casan R, Lozano T, Leach A, Algado JT, Navarro-Diaz FJ. Long-term improvements in insulin prescribing habits and glycaemic control in medical inpatients associated with the introduction of a standardized educational approach. Diabetes Res Clin Pract. 2009;85(2):159–65.
Donihi AC, Gibson JM, Noschese ML, DiNardo MM, Koerbel GL, Curll M, et al. Effect of a targeted glycemic management program on provider response to inpatient hyperglycemia. Endocr Pract. 2011;17(4):552–7.
Munoz M, Pronovost P, Dintzis J, Kemmerer T, Wang NY, Chang YT, et al. Implementing and evaluating a multicomponent inpatient diabetes management program: putting research into practice. Joint Commission journal on quality and patient safety/Joint Commission Resources. 2012;38(5):195–206.
Nirantharakumar K, Chen YF, Marshall T, Webber J, Coleman JJ. Clinical decision support systems in the care of inpatients with diabetes in non-critical care setting: systematic review. Diabet Med. 2012;29(6):698–708.
Wong B, Mamdani MM, Yu CH. Computerized insulin order sets and glycemic control in hospitalized patients. Am J Med. 2016; doi:10.1016/j.amjmed.2016.09.034.
Neubauer KM, Mader JK, Höll B, Aberer F, Donsa K, Augustin T, et al. Standardized glycemic management with a computerized workflow and decision support system for hospitalized patients with type 2 diabetes on different wards. Diabetes Technol Ther. 2015;17(10):685–92.
Gianchandani R, Umpierrez GE. Inpatient use of computer-guided insulin devices moving into the non-intensive care unit setting. Diabetes Technol Ther. 2015;17(10):673–5.
• Aloi J, Bode BW, Ullal J, Chidester P, McFarland RS, Bedingfield AE, et al. Comparison of an electronic glycemic management system versus provider-managed subcutaneous basal bolus insulin therapy in the hospital setting. J Diabetes Sci Technol. 2016; doi:10.1177/1932296816664746. This study showed that Electronic Glycemic Management System (eGMS) achieved glycemic control with less hypoglycemia compared to basal-bolus insulin managed by a prescriber.
Thabit H, Hartnell S, Allen JM, Lake A, Wilinska ME, Ruan Y, et al. Closed-loop insulin delivery in inpatients with type 2 diabetes: a randomised, parallel-group trial. Lancet Diabetes Endocrinol. 2016; doi:10.1016/S2213-8587(16)30280-7.
Wallia A, Umpierrez GE, Nasraway SA, Klonoff DC, Investigators P. Round table discussion on inpatient use of continuous glucose monitoring at the International Hospital Diabetes Meeting. J Diabetes Sci Technol. 2016;10(5):1174–81.
Mendez CE, Ata A, Rourke JM, Stain SC, Umpierrez G. Daily inpatient glycemic survey (DINGS): a process to remotely identify and assist in the management of hospitalized patients with diabetes and hyperglycemia. Endocr Pract. 2015;21(8):927–35.
Boaz M, Landau Z, Matas Z, Wainstein J. Institutional blood glucose monitoring system for hospitalized patients: an integral component of the inpatient glucose control program. J Diabetes Sci Technol. 2009;3(5):1168–74.
O’Neill AE, Miranda D. The right tools can help critical care nurses save more lives. Crit Care Nurs Q. 2006;29(4):275–81.
Thompson R, Schreuder AB, Wisse B, Jarman K, Givan K, Suhr L, et al. Improving insulin ordering safely: the development of an inpatient glycemic control program. J Hosp Med. 2009;4(7):E30–5.
Engle M, Ferguson A, Fields W. A journey to improved inpatient glycemic control by redesigning meal delivery and insulin administration. Clin Nurse Spec. 2016;30(2):117–24.
Lee SY, Askin G, McDonnell ME, Arnold LM, Alexanian SM. Hypoglycemia rates after restriction of high-dose glargine in hospitalized patients. Endocr Pract. 2016; doi:10.4158/EP161288.OR.
Arnold LM, Mahesri M, McDonnell ME, Alexanian SM. Glycemic outcomes three years after implementation of a perioperative glycemic control algorithm in an academic institution. Endocr Pract. 2016; doi:10.4158/EP161354.OR.
Tanner J, Padley W, Assadian O, Leaper D, Kiernan M, Edmiston C. Do surgical care bundles reduce the risk of surgical site infections in patients undergoing colorectal surgery? A systematic review and cohort meta-analysis of 8,515 patients. Surgery. 2015;158(1):66–77.
Levetan CS, Salas JR, Wilets IF, Zumoff B. Impact of endocrine and diabetes team consultation on hospital length of stay for patients with diabetes. Am J Med. 1995;99(1):22–8.
Koproski J, Pretto Z, Poretsky L. Effects of an intervention by a diabetes team in hospitalized patients with diabetes. Diabetes Care. 1997;20(10):1553–5.
Simmons D, Hartnell S, Watts J, Ward C, Davenport K, Gunn E, et al. Effectiveness of a multidisciplinary team approach to the prevention of readmission for acute glycaemic events. Diabetic medicine: a journal of the British Diabetic Association. 2015;32(10):1361–7.
Feddersen E, Lockwood DH. An inpatient diabetes educator’s impact on length of hospital stay. The Diabetes educator. 1994;20(2):125–8.
Horton WB, Weeks AQ, Rhinewalt JM, Ballard RD, Asher FH. Analysis of a guideline-derived resident educational program on inpatient glycemic control. South Med J. 2015;108(10):596–8.
Krinsley JS, Jones RL. Cost analysis of intensive glycemic control in critically ill adult patients. Chest. 2006;129(3):644–50.
Newton CA, Young S. Financial implications of glycemic control: results of an inpatient diabetes management program. Endocrine practice: official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists. 2006;12(Suppl 3):43–8.
Rasekaba TM, Lim WK, Hutchinson AF. Effect of a chronic disease management service for patients with diabetes on hospitalisation and acute care costs. Australian health review: a publication of the Australian Hospital Association. 2012;36(2):205–12.
Crolla RM, van der Laan L, Veen EJ, Hendriks Y, van Schendel C, Kluytmans J. Reduction of surgical site infections after implementation of a bundle of care. PLoS One. 2012;7(9):e44599.
Rubin DJ. Hospital readmission of patients with diabetes. Curr Diab Rep. 2015;15(4):1–9.
Davies M, Dixon S, Currie CJ, Davis RE, Peters JR. Evaluation of a hospital diabetes specialist nursing service: a randomized controlled trial. Diabet Med. 2001;18(4):301–7.
Healy SJ, Black D, Harris C, Lorenz A, Dungan KM. Inpatient diabetes education is associated with less frequent hospital readmission among patients with poor glycemic control. Diabetes Care. 2013;36(10):2960–7.
Dungan K, Lyons S, Manu K, Kulkarni M, Ebrahim K, Grantier C, et al. An individualized inpatient diabetes education and hospital transition program for poorly controlled hospitalized patients with diabetes. Endocr Pract. 2014:1–24.
Kampan P. Effects of counseling and implementation of clinical pathway on diabetic patients hospitalized with hypoglycemia. J Med Assoc Thail. 2006;89(5):619–25.
Wei NJ, Wexler DJ, Nathan DM, Grant RW. Intensification of diabetes medication and risk for 30-day readmission. Diabet Med. 2013;30(2):e56–62.
Wu EQ, Zhou S, Yu A, Lu M, Sharma H, Gill J, et al. Outcomes associated with post-discharge insulin continuity in US patients with type 2 diabetes mellitus initiating insulin in the hospital. Hosp Pract (1995). 2012;40(4):40–8.
Lee PH, Franks AS, Barlow PB, Farland MZ. Hospital readmission and emergency department use based on prescribing patterns in patients with severely uncontrolled type 2 diabetes mellitus. Diabetes Technol Ther. 2014;16(3):150–5.
Seggelke SA, Hawkins RM, Gibbs J, Rasouli N, Wang C, Draznin B. Transitional care clinic for uninsured and Medicaid-covered patients with diabetes mellitus discharged from the hospital: a pilot quality improvement study. Hosp Pract (1995). 2014;42(1):46–51.
Maldonado MR, D’Amico S, Rodriguez L, Iyer D, Balasubramanyam A. Improved outcomes in indigent patients with ketosis-prone diabetes: effect of a dedicated diabetes treatment unit. Endocr Pract. 2003;9(1):26–32.
Rubin D, Donnell-Jackson K, Jhingan R, Golden SH, Paranjape A. Early readmission among patients with diabetes: a qualitative assessment of contributing factors. J Diabetes Complicat. 2014;28(6):869–73.
Dramatic readmission reductions for CABG, CHF, and AMI attributed to Glytec’s eGlycemic Management System. 2016. https://www.glytecsystems.com/News/dramatic-readmission-reductions-for-cabg-chf-and-ami-attributed-to-glytec-s-eglycemic-management-system.html. Accessed 28 Nov 2016.
Centers for Medicare & Medicaid services: readmissions reduction program. https://www.cms.gov/medicare/medicare-fee-for-service-payment/acuteinpatientpps/readmissions-reduction-program.html. November 28, 2016.
Diabetes Technology Meeting. 2016. https://www.diabetestechnology.org/dtm/submitted-abstracts.shtml. Accessed 28 Nov 2016.
•• Rubin DJ, Handorf EA, Golden SH, Nelson DB, McDonnell ME, Zhao H. Development and validation of a novel tool to predict hospital readmission risk among patients with diabetes. Endocr Pract. 2016;22(10):1204–15. This article presents a novel risk prediction tool to identify patients at risk for 30-day readmissions based on readily available clinical and sociodemographic data.